The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The role of CRF and CRF-related peptides in the dark side of addiction
Open accessAbstract
Drug addiction is a chronically relapsing disorder characterized by a compulsion to seek and take drugs, the development of dependence, and the manifestation of a negative emotional state when the drug is removed. Activation of brain stress systems is hypothesized to be a key element of the negative emotional state produced by dependence that drives drug-seeking through negative reinforcement mechanisms, defined as the “dark side” of addiction. The focus of the present review is on the role of corticotropin-releasing factor (CRF) and CRF-related peptides in the dark side of addiction. CRF is a key mediator of the hormonal, autonomic, and behavior responses to stressors. Emphasis is placed on the role of CRF in extrahypothalamic systems in the extended amygdala, including the central nucleus of the amygdala, bed nucleus of the stria terminalis, and a transition area in the shell of the nucleus accumbens, in the dark side of addiction. The urocortin/CRF2 systems have been less explored, but results suggest their role in the neuroadaptation associated with chronic drug use, sometimes in opposition to the effects produced by the CRF1 receptor. Compelling evidence argues that the CRF stress system, including its activation of the hypothalamic-pituitary-adrenal axis, plays a key role in engaging the transition to dependence and maintaining dependence once it is initiated. Understanding the role of the CRF systems in addiction not only provides insight into the neurobiology of the dark side of addiction, but also provides novel targets for identifying vulnerability to addiction and the treatment of addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRF (also termed corticotropin-releasing hormone, although the International Union of Pharmacology designation is CRF) was identified by classic techniques of peptide sequencing (Vale et al., 1981).”
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citationDrug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · cited 4×
“…seek and take the drug, (ii) loss of control in limiting intake, and (iii) emergence of a negative emotional state (e.g., dysphoria, anxiety, irritability) reflecting a motivational withdrawal syndrome when access to the drug is prevented (defined here as dependence) (Koob and Le Moal, 1997, 2008).”
InfluentialSelf-citationCellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Self-citationAllostasis: A New Paradigm to Explain Arousal Pathology
Sterling, P., & Eyer, J. (1988) · Zenodo · doi:10.5281/zenodo.13537700 · Cited by 1,450
Handbook of Life Stress, Cognition and Health
PASTOR, L. H. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1347 · Cited by 1,404
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Specificity in the projection patterns of accumbal core and shell in the rat
Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 4×
“However, with repeated cycles of addiction, a bluntedHPA response occurs but with a sensitized extrahypothalamic CRF stress system response (Koob and Kreek, 2007; Koob, 2008).”
InfluentialSelf-citationPlasticity of reward neurocircuitry and the ‘dark side’ of drug addiction
Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963
Self-citationLewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887
Stress dysregulation of drug reward pathways, and the transition to drug dependence
Koob, & Kreek, M. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05030503 · Cited by 868
Behavioral Medicine: Changing- Health Lifestyles
Colvin, D. F. (1980) · Annals of Behavioral Medicine · doi:10.1093/abm/2.3.27 · Cited by 795
Drug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696
Self-citationCorticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629
Self-citationDeterminants of relapse: Implications for the maintenance of behavior change.
Marlatt, G. A. (1989) · Medical Entomology and Zoology · Cited by 628
Handbook of Life Stress, Cognition and Health
Fisher, S., & REASON, J. T. (1988) · Cited by 575
Further contributions to the study of the evolution of the forebrain
Johnston, J. B. (1923) · Journal of Comparative Neurology · doi:10.1002/cne.900350502 · Cited by 575
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565 · cited 3×
“During alcohol withdrawal, extrahypothalamic CRF systems become hyperactive, with an increase in extracellular CRF within the central nucleus of the amygdala and bed nucleus of the stria terminalis of dependent rats (Merlo-Pich et al., 1995; Olive et al., 2002).”
Self-citationAppetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide
Spina, M., Merlo-Pich, E., Chan, R. K. W., Basso, A. M., Rivier, J., Vale, W., & Koob, G. F. (1996) · Science · doi:10.1126/science.273.5281.1561 · Cited by 564
Self-citationA role for corticotropin releasing factor and urocortin in behavioral responses to stressors
Koob, G. F., & Heinrichs, S. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01991-5 · Cited by 531
Self-citationFink, G. (2000) · Cited by 502
Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499
Self-citationAlcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men.
Cooney, N. L., Litt, M. D., Morse, P. A., Bauer, L. O., & Gaupp, L. (1997) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.106.2.243 · Cited by 479
Swanson, L. W., & Simmons, D. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902850402 · Cited by 478
Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Self-citationPsychological stress, drug-related cues and cocaine craving
Sinha, R., Fuse, T., Aubin, L.-R., & O'Malley, S. S. (2000) · Psychopharmacology · doi:10.1007/s002130000499 · Cited by 463
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462
Imaki, T., Nahan, J., Rivier, C., Sawchenko, P., & Vale, W. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-03-00585.1991 · Cited by 434
Compulsive Drug‐Seeking Behavior and Relapse: Neuroadaptation, Stress, and Conditioning Factors
WEISS, F., CICCOCIOPPO, R., PARSONS, L. H., KATNER, S., LIU, X., ZORRILLA, E. P., VALDEZ, G. R., BEN‐SHAHAR, O., ANGELETTI, S., & RICHTER, R. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03556.x · Cited by 430
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Self-citationMakino, S., Gold, P. W., & Schulkin, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91862-7 · Cited by 400
Brain stress systems in the amygdala and addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.038 · Cited by 388 · cited 1×
“Amygdala CRF tissue content was reduced during acute withdrawal from ethanol exposure and from binge cocaine self-administration (Zorrilla et al., 2001; Funk et al., 2006; Koob, 2009).”
Self-citationBehavioral medicine : changing health lifestyles
Davidson, P. O., & Davidson, S. M. (1980) · Brunner/Mazel eBooks · Cited by 386
Funk, C. K., O'Dell, L. E., Crawford, E. F., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3096-06.2006 · Cited by 381
Self-citationAllostasis, amygdala, and anticipatory angst
Schulkin, J., McEwen, B. S., & Gold, P. W. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90051-5 · Cited by 380 · cited 1×
“…to shut off the HPA axis but can “sensitize” CRF systems in the central nucleus of the amygdala and basolateral amygdala known to be involved in behavioral responses to stressors (Imaki et al., 1991; Makino et al., 1994; Swanson and Simmons, 1989; Schulkin et al., 1994; Shepard et al., 2000).”
Piazza, P. V., & Le Moal, M. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00025-8 · Cited by 374
Wang, B., Shaham, Y., Zitzman, D., Azari, S., Wise, R. A., & You, Z.-B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0955-05.2005 · Cited by 369
Liu, X., & Weiss, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07856.2002 · Cited by 359
Corticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation
Heinrichs, S. C., & Koob, G. F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052092 · Cited by 353
Self-citationCRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat
Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., & Britton, K. T. (1991) · Psychopharmacology · doi:10.1007/bf02244208 · Cited by 353
Self-citationThe Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 351
Enhanced Alcohol Self‐Administration after Intermittent Versus Continuous Alcohol Vapor Exposure
O'Dell, L. E., Roberts, A. J., Smith, R. T., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000145781.11923.4e · Cited by 342
Self-citationErb, S., Shaham, Y., & Stewart, J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05529.1998 · Cited by 329
Shepard, J. D., Barron, K. W., & Myers, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02019-9 · Cited by 321 · cited 1×
“…to shut off the HPA axis but can “sensitize” CRF systems in the central nucleus of the amygdala and basolateral amygdala known to be involved in behavioral responses to stressors (Imaki et al., 1991; Makino et al., 1994; Swanson and Simmons, 1989; Schulkin et al., 1994; Shepard et al., 2000).”
Rimondini, R., Arlinde, C., Sommer, W., & Heilig, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 321
Piazza, P. V., Deroche, V, Deminière, J. M., Maccari, S., Le Moal, M., & Simon, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11738 · Cited by 311
Piecing together the Puzzle of Basal Forebrain Anatomy
Heimer, L., & Alheid, G. F. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-0145-6_1 · Cited by 310 · cited 1×
“CRF drives the orticotropic hormone (ACTH) in the portal system of the brainstem and mediates arousal and behavioral responses ions, and ventral midbrain such as the ventral tegmental medial nucleus accumbens (i.e., posterior shell) (Johnston, 1923; Heimer and Alheid, 1991).”
Lê, A. D., Harding, S., Juzytsch, W., Watchus, J., Shalev, U., & Shaham, Y. (2000) · Psychopharmacology · doi:10.1007/s002130000411 · Cited by 310
Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309
Shaham, Y., Funk, D., Erb, S., Brown, T. J., Walker, C.-D., & Stewart, J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02605.1997 · Cited by 308
Shaham, Y., Erb, S., Leung, S., Buczek, Y., & Stewart, J. (1998) · Psychopharmacology · doi:10.1007/s002130050608 · Cited by 302
Goeders, N. E. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.785 · Cited by 286
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
Self-citationLu, L., Shepard, J. D., Scott Hall, F., & Shaham, Y. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00073-3 · Cited by 276
Allostasis, Homeostasis, and the Costs of Physiological Adaptation
(2004) · Cambridge University Press eBooks · doi:10.1017/cbo9781316257081 · Cited by 261
Sarnyai, Z., Bíró, É., Gardi, J., Vecsernyés, M., Julesz, J., & Telegdy, G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00043-p · Cited by 255
ASTON‐JONES, G., DELFS, J. M., DRUHAN, J., & ZHU, Y. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09284.x · Cited by 250
Zorrilla, E., Valdez, G., & Weiss, F. (2001) · Psychopharmacology · doi:10.1007/s002130100773 · Cited by 246
George, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245
Self-citationPhysiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs
Fekete, É. M., & Zorrilla, E. P. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.09.002 · Cited by 243
Li, C., Vaughan, J., Sawchenko, P. E., & Vale, W. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00991.2002 · Cited by 239
Gehlert, D. R., Cippitelli, A., Thorsell, A., Lê, A. D., Hipskind, P. A., Hamdouchi, C., Lu, J., Hembre, E. J., Cramer, J., Song, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4985-06.2007 · Cited by 239
Olive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237
Heinrichs, S. C., Menzaghi, F., Schulteis, G., Koob, G. F., & Stinus, L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199501000-00011 · Cited by 226
Self-citationChronic Daily Ethanol and Withdrawal: 1. Long-Term Changes in the Hypothalamo-Pituitary-Adrenal Axis
Rasmussen, D. D., Boldt, B. M., Bryant, C. A., Mitton, D. R., Larsen, S. A., & Wilkinson, C. W. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200012000-00013 · Cited by 216
Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use
Blomeyer, D., Treutlein, J., Esser, G., Schmidt, M. H., Schumann, G., & Laucht, M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.026 · Cited by 211
Richter, R. M., & Weiss, F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990615)32:4%3c254::aid-syn2%3e3.0.co;2-h · Cited by 207
Wang, B., You, Z.-B., Rice, K. C., & Wise, R. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0782-3 · Cited by 207
Marinelli, P. W., Funk, D., Juzytsch, W., Harding, S., Rice, K. C., Shaham, Y., & Lê, A. D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0905-x · Cited by 191
Basso, A. M., Spina, M., Rivier, J., Vale, W., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130051028 · Cited by 190
Self-citationValdez, G. R., Zorrilla, E. P., Roberts, A. J., & Koob, G. F. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00020-x · Cited by 186
Self-citationTreutlein, J., Kissling, C., Frank, J., Wiemann, S., Dong, L., Depner, M., Saam, C., Lascorz, J., Soyka, M., Preuss, U. W., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001813 · Cited by 186
Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi, F., Howard, R. L., Heinrichs, S. C., Vale, W., Rivier, J., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38740-9 · Cited by 181
Self-citationModulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
Overstreet, D. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.010 · Cited by 172
Can induced moods trigger drug-related responses in opiate abuse patients?
Childress, A. R., Ehrman, R., McLellan, A. T., MacRae, J., Natale, M., & O'Brien, C. P. (1994) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)90060-4 · Cited by 171 · cited 1×
“Negative affect, stress, or withdrawalrelated distress also increases drug craving (Childress et al., 1994; Cooney et al., 1997; Sinha et al., 2000).”
Chu, K., Koob, G. F., Cole, M., Zorrilla, E. P., & Roberts, A. J. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.03.009 · Cited by 170
Self-citationA neuroendocrine role in cocaine reinforcement
Goeders, N. E. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00027-9 · Cited by 170
The basal forebrain : anatomy to function
Napier, T. C., Kalivas, P. W., & Hanin, I. (1991) · Plenum Press eBooks · Cited by 169
Lowman, C., Allen, J., & Stout, R. L. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02327.x · Cited by 163
Role of Corticotropin-Releasing Factor (CRF) Receptors in the Anorexic Syndrome Induced by CRF
Pelleymounter, M. A., Joppa, M. A., Carmouché, M., Cullen, M. J., Brown, B. T., Murphy, B., Grigoriadis, D. E., Ling, N., & Foster, A. C. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39300-0 · Cited by 162
CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats
Specio, S. E., Wee, S., O’Dell, L. E., Boutrel, B., Zorrilla, E. P., & Koob, G. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0983-9 · Cited by 144
Self-citationHeinrichs, S. C., Menzaghi, F., Pich, E. M., Baldwin, H. A., Rassnick, S., Britton, K. T., & Koob, G. F. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380104 · Cited by 143 · cited 1×
“…response to activation and stress in rodents, and administration of competitive CRF receptor antagonists generally has anti-stress effects (Heinrichs et al., 1994; Menzaghi et al., 1994; Spina et al., 2000; for reviews, see Dunn andBerridge, 1990; Koob et al., 1994, 2001; Sarnyai et al.,…”
Self-citationCorticotropin releasing factor, stress and behavior
Koob, G. F., Heinrichs, S. C., Menzaghi, F., Pich, E. M., & Britton, K. T. (1994) · Seminars in Neuroscience · doi:10.1006/smns.1994.1029 · Cited by 141
Self-citationStinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139
Self-citationAlcohol withdrawal symptoms and drinking behavior.
Hershon, H. I. (1977) · Journal of Studies on Alcohol · doi:10.15288/jsa.1977.38.953 · Cited by 139
Bruijnzeel, A. W., Prado, M., & Isaac, S. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.010 · Cited by 139
Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety
Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132 · cited 1×
“…with increased stress responsiveness (Koob and Heinrichs, 1999), and CRF2 receptor activation is associatedwith decreases in feeding and decreased stress responsiveness (Spina et al., 1996; Pelleymounter et al., 2000; but see Ho et al., 2001; Takahashi et al., 2001; Fekete and Zorrilla, 2007).”
Nibbling at CRF receptor control of feeding and gastrocolonic motility
Zorrilla, E. P., Taché, Y., & Koob, G. F. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00177-9 · Cited by 132
Self-citationValdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
Self-citationSB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats
Knapp, D. J., Overstreet, D. H., Moy, S. S., & Breese, G. R. (2004) · Alcohol · doi:10.1016/j.alcohol.2003.08.007 · Cited by 130
Breese, G. R., Overstreet, D. H., Knapp, D. J., & Navarro, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300706 · Cited by 124 · cited 1×
“…intracerebroventricularly or systemically also blocked the potentiated anxiety-like responses to stressors observed during protracted abstinence (Breese et al., 2005; Valdez et al., 2003) and the increased ethanol selfadministration associated with protracted abstinence (Sabino et al., 2006;…”
ZYWIAK, W. H., CONNORS, G. J., MAISTO, S. A., & WESTERBERG, V. S. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02332.x · Cited by 121
Gilpin, N. W., Richardson, H. N., & Koob, G. F. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00745.x · Cited by 120
Self-citationContarino, A., & Papaleo, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506999102 · Cited by 118
The Edinger-Westphal–Lateral Septum Urocortin Pathway and Its Relationship to Alcohol Consumption
Bachtell, R. K., Weitemier, A. Z., Galván-Rosas, A., Tsivkovskaia, N. O., Risinger, F. O., Phillips, T. J., Grahame, N. J., & Ryabinin, A. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02477.2003 · Cited by 112
Bruijnzeel, A. W., Zislis, G., Wilson, C., & Gold, M. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301192 · Cited by 110
Funk, C. K., & Koob, G. F. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.009 · Cited by 109
Self-citationSabino, V., Cottone, P., Koob, G. F., Steardo, L., Lee, M. J., Rice, K. C., & Zorrilla, E. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0546-5 · Cited by 108
Self-citationSchmid, B., Blomeyer, D., Treutlein, J., Zimmermann, U. S., Buchmann, A. F., Schmidt, M. H., Esser, G., Rietschel, M., Banaschewski, T., Schumann, G., et al. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990290 · Cited by 103
MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist
RICHARDSON, H., ZHAO, Y., Fekete, É. M., FUNK, C., Wirsching, P., Janda, K. D., Zorrilla, E. P., & Koob, G. F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.10.008 · Cited by 101
Self-citationRyabinin, A. E., Galván-Rosas, A., Bachtell, R. K., & Risinger, F. O. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1284-y · Cited by 98
Ho, S. P., Takahashi, L. K., Livanov, V., Spencer, K. R., Lesher, T., Maciag, C. M., Smith, M. A., Rohrbach, K. W., Hartig, P. R., & Arnerić, S. P. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00050-x · Cited by 89
Richter, R. M., Zorrilla, E. P., Basso, A. M., Koob, G. F., & Weiss, F. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb01979.x · Cited by 89
Self-citationAllostatic view of motivation: implications for psychopathology.
Koob, G. F. (2004) · PubMed · Cited by 89
Self-citationGreenwell, T. N., Funk, C. K., Cottone, P., Richardson, H. N., Chen, S. A., Rice, K. C., Zorrilla, E. P., & Koob, G. F. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00142.x · Cited by 87
Self-citationFacilitation of ethanol consumption by intracerebroventricular infusions of corticosterone
Fahlke, C., rd, E. H., & Hansen, S. (1996) · Psychopharmacology · doi:10.1007/bf02805986 · Cited by 83
The urocortin 1 neurocircuit: Ethanol-sensitivity and potential involvement in alcohol consumption
Ryabinin, A. E., & Weitemier, A. Z. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.007 · Cited by 76
Studies on duration of a late recovery period after chronic abuse of ethanol
Alling, C., Balldin, J., Bokström, K., Gottfries, C. G., Karlsson, I., & Långström, G. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb06720.x · Cited by 75
Behavioral Effects of Central Administration of The Novel CRF Antagonist Astressin in Rats
Spina, M. G. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00108-6 · Cited by 75
Sharp, B. M., & Matta, S. G. (1993) · Endocrinology · doi:10.1210/endo.133.1.8391419 · Cited by 74
Liu, J., Yu, B., Orozco-Cabal, L. F., Grigoriadis, D. E., Rivier, J., Vale, W., Shinnick‐Gallagher, P., & Gallagher, J. P. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4196-04.2005 · Cited by 73
Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics
Annis, H. M., Sklar, S. M., & Moser, A. E. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(97)00024-5 · Cited by 72
Pastor, R., McKinnon, C. S., Scibelli, A. C., Burkhart‐Kasch, S., Reed, C. L., Ryabinin, A. E., Coste, S. C., Stenzel‐Poore, M. P., & Phillips, T. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710181105 · Cited by 71
Bachtell, R. K., Tsivkovskaia, N. O., & Ryabinin, A. E. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00174-4 · Cited by 71
Motivational factors in the etiology of drug abuse
Bevins, R. A., Bardo, M. T., & Koob, G. F. (2004) · Cited by 65
Self-citationSemba, J., Wakuta, M., Maeda, J., & Suhara, T. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00024-6 · Cited by 56
Ryabinin, A. E., Yoneyama, N., Tanchuck, M. A., Mark, G. P., & Finn, D. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.014 · Cited by 55
Disruption of the CRF2 Receptor Pathway Decreases the Somatic Expression of Opiate Withdrawal
Papaleo, F., Ghozland, S. G., Ingallinesi, M., Roberts, A. J., Koob, G. F., & Contarino, A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.8 · Cited by 48
Self-citationDistribution of corticotropin-releasing factor-like immunoreactivity in human brain
Charlton, B. G., Ferrier, I. N., & Perry, R. H. (1987) · Neuropeptides · doi:10.1016/s0143-4179(87)90083-7 · Cited by 43
Koob, G. F., & Moal, M. L. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9781316257081.008 · Cited by 42
Self-citationTurek, V. F., Tsivkovskaia, N. O., Hyytiä, P., Harding, S. E., Lê, A. D., & Ryabinin, A. E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0011-x · Cited by 40
Tucci, S., Cheeta, S., Seth, P., & File, S. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1403-4 · Cited by 38
Spangler, E., Cote, D. M., Anacker, A. M. J., Mark, G. P., & Ryabinin, A. E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.030 · Cited by 36
Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice
Sharpe, A. L., & Phillips, T. J. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832f01ba · Cited by 31
Skelton, K. H., Gutman, D. A., Thrivikraman, K. V., Nemeroff, C. B., & Owens, M. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0713-3 · Cited by 28
Sharpe, A. L., Coste, S. C., Burkhart‐Kasch, S., Li, N., Stenzel‐Poore, M. P., & Phillips, T. J. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000179371.46716.5e · Cited by 28
Guan, X., Zhang, R., Xu, Y., & Li, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.035 · Cited by 24
The Biological Basis of Cocaine Addiction
Quiñones-Jenab, V. (2001) · Medical Entomology and Zoology · Cited by 17
The roles of urocortins 1, 2, and 3 in the brain
Zorrilla, E. P., & Koob, G. F. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80013-6 · Cited by 15
Self-citationMolecular Genetic Approaches to the Neuropharmacology of Corticotropin-Releasing Factor
Koob, G. F., Bartfai, T., & Roberts, A. J. (2001) · International Journal of Comparative Psychology · doi:10.46867/c4cp4b · Cited by 9
Self-citation
Cited by
Reward mechanisms in obesity: new insights and future directions
Kenny, P. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.016 · Cited by 748
Lopez-Quintero, C., Cobos, J. P. D. L., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.004 · Cited by 704
Stress and the HPA axis: role of glucocorticoids in alcohol dependence
Stephens, M. (2012) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v34.4.11 · Cited by 571
Volkow, N. D., Wang, G., Fowler, J. S., Tomasi, D., Telang, F., & Baler, R. (2010) · BioEssays · doi:10.1002/bies.201000042 · Cited by 532
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Metadata
- Authors
- Koob, G. F.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 1314
- Pages
- 3-14
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2005020429
- Cited by
- 290
- References
- 141
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.